Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Return on Capital Employed (2016 - 2026)

Bio-Techne has reported Return on Capital Employed over the past 16 years, most recently at 4.91% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 297.0% year-over-year to 4.91%; the TTM value through Dec 2025 reached 4.91%, down 297.0%, while the annual FY2025 figure was 4.17%, 406.0% down from the prior year.
  • Return on Capital Employed for Q4 2025 was 4.91% at Bio-Techne, up from 4.59% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 13.98% in Q2 2022 and troughed at 4.22% in Q2 2025.
  • A 5-year average of 10.02% and a median of 11.17% in 2021 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: surged 348bps in 2021 and later plummeted -422bps in 2024.
  • Year by year, Return on Capital Employed stood at 12.32% in 2021, then rose by 8bps to 13.25% in 2022, then decreased by -22bps to 10.3% in 2023, then decreased by -24bps to 7.88% in 2024, then crashed by -38bps to 4.91% in 2025.
  • Business Quant data shows Return on Capital Employed for TECH at 4.91% in Q4 2025, 4.59% in Q3 2025, and 4.22% in Q2 2025.